Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Gains from Investment Securities: 2022-2024

Historic Gains from Investment Securities for Ardent Health (ARDT) over the last 3 years, with FY2024 value amounting to $41.6 million.

  • Ardent Health's Gains from Investment Securities fell 12160.8% to -$172000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $306000.0, marking a year-over-year decrease of 5853.66%. This contributed to the annual value of $41.6 million for FY2024, which is 11408.43% up from last year.
  • According to the latest figures from FY2024, Ardent Health's Gains from Investment Securities is $41.6 million, which was up 11408.43% from $19.4 million recorded in FY2023.
  • Ardent Health's Gains from Investment Securities' 5-year high stood at $55.8 million during FY2022, with a 5-year trough of $19.4 million in FY2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $41.6 million (2024), whereas its average is $39.0 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 6518.51% in 2023, then soared by 11408.43% in 2024.
  • Annual analysis of 3 years shows Ardent Health's Gains from Investment Securities stood at $55.8 million in 2022, then plummeted by 65.19% to $19.4 million in 2023, then surged by 114.08% to $41.6 million in 2024.
  • Its Gains from Investment Securities stands at $41.6 million for FY2024, versus $19.4 million for FY2023 and $55.8 million for FY2022.